Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

R-Pharm presented results of phase III global research program for rheumatoid arthritis drug, novel IL-6 inhibitor Olokizumab

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...

Expert RA assigns an expected ruA credit rating to Binnopharm Group’s planned bond issue

Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...

Russian Health Ministry recommends RA drug olokizumab for patients with COVID-19 of any severity

The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...

Promomed Group received approval for the first drug in its portfolio for treatment of HIV infection

Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...

“Russian Big Pharma must do a 180 degree turn in its way of thinking” Vikram Punia says

A plenary session where Denis Manturov, Minister of Industry and Trade, and Mikhail Murashko, Minister of Health, participated focused on the issue of “Future...
spot_img

Expert Articles

spot_img